Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone

Bibliographic Details
Main Author:	Ross M. Colquhoun
Format:	Article
Language:	English
Published:	SAGE Publishing 2013-05-01
Series:	Substance Abuse: Research and Treatment
Online Access:	http://www.la-press.com/open-label-trial-of-naltrexone-implants-measuring-blood-serum-levels-o-article-a3675

Similar Items

Naltrexone Implant for Opioid Use Disorder
by: Amber N. Edinoff, et al.
Published: (2021-12-01)

Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
by: Koch Monika, et al.
Published: (2005-04-01)

Safety of naltrexone in patients with cirrhosis
by: Rachel Thompson, et al.
Published: (2024-07-01)

Naltrexone‐induced drug eruption
by: Johannes Heck, et al.
Published: (2020-10-01)

Low Dose Naltrexone - Efficacy and safety of off-label use therapy.
by: Andrzej Stańczak
Published: (2020-01-01)

Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
by: Dahlberg S, et al.
Published: (2022-09-01)

Dyskinesias occur in response to saline and naltrexone alone after priming with combination of dopaminergic agents and naltrexone in the MPTP parkinsonian monkeys
by: Pershia Samadi, et al.
Published: (2005-06-01)

Naltrexone, a therapeutic alternative in Darier disease
by: Dennise L. Smith-Pellegrin, et al.
Published: (2021-10-01)

Trial protocol of an open-label pilot study of oral naltrexone–bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)
by: Jonathan Brett, et al.
Published: (2025-02-01)

Naltrexone-induced acute generalized exanthematous pustulosis
by: Jason Eakes, BS, et al.
Published: (2023-09-01)

Effects of genotype and food on naltrexone exposure in adolescents
by: Stephani L. Stancil, et al.
Published: (2022-11-01)

Impact of naltrexone preventation of relapse opiate dependence
by: Nazer Mohammad, et al.
Published: (2006-02-01)

The Potential Role of Naltrexone in Borderline Personality Disorder
by: Azadeh Moghaddas, et al.
Published: (2017-04-01)

Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT
by: John Strang, et al.
Published: (2019-01-01)

Microbiological Estimation of Nasal Spray Containing Naltrexone Hydrochloride
by: Yu. M. Domnina, et al.
Published: (2020-11-01)

The effects of naltrexone in autistic children: report of two cases
by: F Akkök
Published: (1995-01-01)

Naltrexone Treatment for Methamphetamine Dependence – Service Evaluation Audit
by: Emma Stimson, et al.
Published: (2024-06-01)

Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)

The importance of dosage for naltrexone treatment in Hailey-Hailey disease
by: Chloé Grolleau, MD, MSc, et al.
Published: (2022-05-01)

Thyroid Function of Former Opioid Addicts on Naltrexone Treatment
by: Ioannis Ilias, et al.
Published: (2001-01-01)

Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
by: Karlo Toljan, et al.
Published: (2018-09-01)

Naltrexone blocks endorphins released when dancing in synchrony
by: Tarr, B, et al.
Published: (2017)

Monitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder
by: Perez-Macia V, et al.
Published: (2021-05-01)

RATIONALE FOR THE SELECTION OF AUXILIARY COMPONENTS FOR THE NALTREXONE HYDROCHLORIDE NASAL SPRAY
by: Y. M. Domnina, et al.
Published: (2019-01-01)

Quantitative Determination of Benzalconium Chloride in the Naltrexone Hydrochloride Nasal Spray
by: Yu. M. Domnina, et al.
Published: (2020-11-01)

3494 Naltrexone as a Diagnostic Tool in Ocular Neuropathic Pain
by: Nicholas Fowler, et al.
Published: (2019-03-01)

Dominant Dystrophic Epidermolysis Bullosa Pruriginosa Responding to Naltrexone Treatment
by: Kristine A.U. Pallesen, et al.
Published: (2019-09-01)

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
by: Peindl K, et al.
Published: (2011-06-01)

Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence
by: Kimberly L. Kjome, et al.
Published: (2011-02-01)

Naltrexone extended-release injection: an option for the management of opioid abuse
by: Taylor Jr R, et al.
Published: (2011-12-01)

The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
by: Daniel Jackson, et al.
Published: (2021-02-01)

Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.
by: Jennifer Prah Ruger, et al.
Published: (2012-01-01)

Analysis of naltrexone and its metabolite 6-beta-naltrexol in serum with high-performance liquid chromatography
by: Heinälä Pekka, et al.
Published: (2012-08-01)

Low-dose naltrexone as a treatment for vulvodynia: A case series
by: Renee T. Sullender, et al.
Published: (2025-03-01)

Study of Acute Toxicity and Irritant Effect of Nasal Spray Naltrexone Hydrochloride
by: Yu. M. Domnina, et al.
Published: (2021-05-01)

Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program
by: Reece AS
Published: (2007-11-01)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
by: Mitchell R. K. L. Lie, et al.
Published: (2018-03-01)

Determination Of Naltrexone Dosage For Narcotic Agonist Blockade In Detoxified Asian Addicts.
by: Jamaludin, Ailene, et al.
Published: (1988)

A Narrative Review on Bio-Physiology of Naltrexone Treatment in Pornography Addiction
by: H. Ravish, et al.
Published: (2024-04-01)

Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures
by: Saul Rodriguez, et al.
Published: (2024-06-01)